# CVM GFI #299 -Dual Labeling for Fully Approved and Conditionally Approved New Animal Drugs with a New World Screwworm-Related Indication:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-299-dual-labeling-for-fully-approved-and-conditionally-approved-new-animal-drugs-with-a-new-world-screwworm-related-indication-guidance-for-industry/f3901b25-31a8-481c-abe2-0be5e9380650

> FDA guidance document: CVM GFI #299 -Dual Labeling for Fully Approved and Conditionally Approved New Animal Drugs with a New World Screwworm-Related Indication:  Guidance for Industry. Issue date: October 14, 2025. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #299 -Dual Labeling for Fully Approved and Conditionally Approved New Animal Drugs with a New World Screwworm-Related Indication:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2025-10-14
- Last Changed: 2025-10-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2025-D-4500">FDA-2025-D-4500</a>

## Related Documents

- [Compliance Policy for Certain Compounding of Oral Oxitriptan (5-HTP) Drug Products for Patients With Tetrahydrobiopterin (BH4) Deficiency Immediately in Effect Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/compliance-policy-for-certain-compounding-of-oral-oxitriptan-5-htp-drug-products-for-patients-with-tetrahydrobiopterin-bh4-deficiency-immediately-in-effect-guidance-for-industry/d88af3f7-de54-4f46-bcc5-9dd57bf5f149)
- [Temporary Policies for Compounding Certain Parenteral Drug Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/temporary-policies-for-compounding-certain-parenteral-drug-products-guidance-for-industry/46ee42bb-92f0-47bf-a6e8-2980ea59392a)
- [CVM GFI #156 Comparability Protocols - Chemistry, Manufacturing, and Controls Information for New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-156-comparability-protocols-chemistry-manufacturing-and-controls-information-for-new-animal-drugs/3b46eda7-635e-4041-aff7-92c21da620bb)